Disturbed cingulate glutamate metabolism in adults with high-functioning autism spectrum disorder: Evidence in support of the excitatory/inhibitory imbalance hypothesis

Molecular Psychiatry

Volumn 19, Issue 12, 2014, Pages 1314-1325

  Tebartz Van Elst, L ^a   Maier, S ^a   Fangmeier, T ^a   Endres, D ^a   Mueller, G T ^a   Nickel, K ^a   Ebert, D ^a   Lange, T ^a,b   Hennig, J ^b   Biscaldi, M ^a   Riedel, A ^a   Perlov, E ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; GLUTAMIC ACID; GLUTAMINE; N ACETYLASPARTIC ACID; ASPARTIC ACID; N-ACETYLASPARTATE;

ACADEMIC ACHIEVEMENT; ADULT; ANTERIOR CINGULATE; ARTICLE; ASPERGER SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOTHESIS; LONGITUDINAL STUDY; MALE; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PSYCHOMETRY; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; AUTISM; BRAIN MAPPING; CEREBELLUM; CINGULATE GYRUS; PSYCHOLOGY;

ADULT; ASPARTIC ACID; BRAIN MAPPING; CEREBELLUM; CHILD DEVELOPMENT DISORDERS, PERVASIVE; FEMALE; GLUTAMIC ACID; GLUTAMINE; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PSYCHOMETRICS;

EID: 84927178221     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2014.62     Document Type: Article

References (124)

1. Centers for Disease Control and Prevention. Epidemiology, Autism Spectrum Disorder. http://www.cdc.gov/ncbddd/autism/data.html 4-7-2013
2. Brugha TS, McManus S, Bankart J, Scott F, Purdon S, Smith J., et al. Epidemiology of autism spectrum disorders in adults in the community in England. Arch Gen Psychiatry 2011; 68: 459-465
3. Kim YS, Leventhal BL, Koh YJ, Fombonne E, Laska E, Lim EC., et al. Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatry 2011; 168: 904-912
4. Hofvander B, Delorme R, Chaste P, Nydén A, Wentz E, Ståhlberg O., et al. Psychiatric and psychosocial problems in adults with normal-intelligence autism spectrum disorders. BMC Psychiatry 2009; 9: 35
5. Tebartz Van Elst L, Pick M, Biscaldi M, Fangmeier T, Riedel A. High-functioning autism spectrum disorder as a basic disorder in adult psychiatry and psychotherapy: psychopathological presentation, clinical relevance and therapeutic concepts. Eur Arch Psychiatry Clin Neurosci 2013; 263(Suppl 2): S189-S196
6. Levy SE, Mandell DS, Schultz RT. Autism. Lancet 2009; 374: 1627-1638
7. Moreno-De-Luca A, Myers SM, Challman TD, Moreno-De-Luca D, Evans DW, Ledbetter DH. Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence. Lancet Neurol 2013; 12: 406-414
8. Cohen D, Pichard N, Tordjman S, Baumann C, Burglen L, Excoffier E., et al. Specific genetic disorders and autism: clinical contribution towards their identification. J Autism Dev Disord 2005; 35: 103-116
9. Lord C, Petkova E, Hus V, Gan W, Lu F, Martin DM., et al. A multisite study of the clinical diagnosis of different autism spectrum disorders. Arch Gen Psychiatry 2012; 69: 306-313
10. Sharma S, Woolfson LM, Hunter SC. Confusion and inconsistency in diagnosis of Asperger syndrome: a review of studies from 1981 to 2010. Autism 2012; 16: 465-486
11. Persico AM, Napolioni V. Autism genetics. Behav Brain Res 2013; 251: 95-112
12. Van Harssel JJ, Weckhuysen S, Van Kempen MJ, Hardies K, Verbeek NE, de Kovel CG et al. Clinical and genetic aspects of PCDH19-related epilepsy syndromes and the possible role of PCDH19 mutations in males with autism spectrum disorders. Neurogenetics 2013; 14: 23-34
13. Munoz-Yunta JA, Palau-Baduell M, Salvadó-Salvadó B, Valls-Santasusana A, Rosendo-Moreno N, Clofent-Torrentó et al. Autism, epilepsy and genetics. Rev Neurol 2008; 46(Suppl 1): S71-S77
14. Chao HT, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J et al. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 2010; 468: 263-269
15. Tarabeux J, Kebir O, Gauthier J, Hamdan FF, Xiong L, Piton A et al. Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia. Transl Psychiatry 2011; 1: e55
16. Rubenstein JL. Three hypotheses for developmental defects that may underlie some forms of autism spectrum disorder. Curr Opin Neurol 2010; 23: 118-123
17. Rubenstein JL, Merzenich MM. Model of autism: increased ratio of excitation/ inhibition in key neural systems. Genes Brain Behav 2003; 2: 255-267
18. Casanova MF, Buxhoeveden D, Gomez J. Disruption in the inhibitory architecture of the cell minicolumn: implications for autism. Neuroscientist 2003; 9: 496-507
19. Essa MM, Braidy N, Vijayan KR, Subash S, Guillemin GJ. Excitotoxicity in the pathogenesis of autism. Neurotox Res 2013; 23: 393-400
20. Maski KP, Jeste SS, Spence SJ. Common neurological co-morbidities in autism spectrum disorders. Curr Opin Pediatr 2011; 23: 609-615
21. Ballaban-Gil K, Tuchman R. Epilepsy and epileptiform EEG: association with autism and language disorders. Ment Retard Dev Disabil Res Rev 2000; 6: 300-308
22. Spence SJ, Schneider MT. The role of epilepsy and epileptiform EEGs in autism spectrum disorders. Pediatr Res 2009; 65: 599-606
23. Tebartz Van Elst L, Perlov E. Epilepsy & Psyche. Psychische Störungen bei Epilepsie, Epileptische Phänomene in der Psychiatrie. Kohlhammer Verlag: Göttingen, Germany, 2013
24. Jamain S, Betancur C, Quach H, Philippe A, Fellous M, Giros B et al. Linkage and association of the glutamate receptor 6 gene with autism. Mol Psychiatry 2002; 7: 302-310
25. Buttenschon HN, Lauritsen MB, El Daoud A, Hollegaard M, Jorgensen M, Tvedegaard K et al. A population-based association study of glutamate decarboxylase 1 as a candidate gene for autism. J Neural Transm 2009; 116: 381-388
26. Butler PD, Zemon V, Schechter I, Saperstein AM, Hoptman MJ, Lim KO et al. Earlystage visual processing and cortical amplification deficits in schizophrenia. Arch Gen Psychiatry 2005; 62: 495-504
27. Yang Y, Pan C. Role of metabotropic glutamate receptor 7 in autism spectrum disorders: a pilot study. Life Sci 2013; 92: 149-153
28. Won H, Lee HR, Gee HY, Mah W, Kim JI, Lee J et al. Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 2012; 486: 261-265
29. Kelleher RJ III, Geigenmüller U, Hovhannisyan H, Trautman E, Pinard R, Rathmell B et al. High-throughput sequencing of mGluR signaling pathway genes reveals enrichment of rare variants in autism. PLoS One 2012; 7: e35003
30. Mehta MV, Gandal MJ, Siegel SJ. mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism. PLoS One 2011; 6: e26077
31. Jacob S, Brune CW, Badner JA, Ernstrom K, Courchesne E, Lord C et al. Familybased association testing of glutamate transporter genes in autism. Psychiatr Genet 2011; 21: 212-213
32. Turunen JA, Rehnström K, Kilpinen H, Kuokkanen M, Kempas E, Ylisaukko-Oja T. Mitochondrial aspartate/glutamate carrier SLC25A12 gene is associated with autism. Autism Res 2008; 1: 189-192
33. Autism Genome Project Consortium, Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 2007; 39: 319-328
34. Ramoz N, Reichert JG, Smith CJ, Silverman JM, Bespalova IN, Davis KL et al. Linkage and association of the mitochondrial aspartate/glutamate carrier SLC25A12 gene with autism. Am J Psychiatry 2004; 161: 662-669
35. Bristot Silvestrin R, Bambini-Junior V, Galland F, Daniele Bobermim L, Quincozes- Santos A, Torres Abib R et al. Animal model of autism induced by prenatal exposure to valproate: altered glutamate metabolism in the hippocampus. Brain Res 2013; 1495: 52-60
36. Markram K, Markram H. The intense world theory-a unifying theory of the neurobiology of autism. Front Hum Neurosci 2010; 4: 224
37. Purcell AE, Jeon OH, Zimmerman AW, Blue ME, Pevsner J. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 2001; 57: 1618-1628
38. Shimmura C, Suda S, Tsuchiya KJ, Hashimoto K, Ohno K, Matsuzaki H et al. Alteration of plasma glutamate and glutamine levels in children with highfunctioning autism. PLoS One 2011; 6: e25340
39. Shimmura C, Suzuki K, Iwata Y, Tsuchiya KJ, Ohno K, Matsuzaki H et al. Enzymes in the glutamate-glutamine cycle in the anterior cingulate cortex in postmortem brain of subjects with autism. Mol Autism 2013; 4: 6
40. Carlsson ML. Hypothesis: is infantile autism a hypoglutamatergic disorder? Relevance of glutamate-serotonin interactions for pharmacotherapy. J Neural Transm 1998; 105: 525-535
41. Fatemi SH. The hyperglutamatergic hypothesis of autism. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 911
42. Fatemi SH, Halt AR, Stary JM, Kanodia R, Schulz SC, Realmuto GR. Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol Psychiatry 2002; 52: 805-810
43. Baruth JM, Wall CA, Patterson MC, Port JD. Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review. Autism Res 2013; 6: 119-133
44. Tebartz Van Elst LT, Valerius G, Büchert M, Thiel T, Rüsch N, Bubl E et al. Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study. Biol Psychiatry 2005; 58: 724-730
45. Bartha R, Williamson PC, Drost DJ, Malla A, Carr TJ, Cortese L et al. Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 1997; 54: 959-965
46. Corrigan NM, Shaw DW, Richards TL, Estes AM, Friedman SD, Petropoulos H et al. Proton magnetic resonance spectroscopy and MRI reveal no evidence for brain mitochondrial dysfunction in children with autism spectrum disorder. J Autism Dev Disord 2012; 42: 105-115
47. Bernardi S, Anagnostou E, Shen J, Kolevzon A, Buxbaum JD, Hollander E et al. In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism. Brain Res 2011; 1380: 198-205
48. Fujii E, Mori K, Miyazaki M, Hashimoto T, Harada M, Kagami S. Function of the frontal lobe in autistic individuals: a proton magnetic resonance spectroscopic study. J Med Invest 2010; 57: 35-44
49. Suzuki K, Nishimura K, Sugihara G, Nakamura K, Tsuchiya KJ, Matsumoto K et al. Metabolite alterations in the hippocampus of high-functioning adult subjects with autism. Int J Neuropsychopharmacol 2010; 13: 529-534
50. Montag C, Schubert F, Heinz A, Gallinat J. Prefrontal cortex glutamate correlates with mental perspective-taking. PLoS One 2008; 3: e3890
51. Hardan AY, Minshew NJ, Melhem NM, Srihari S, Jo B, Bansal R et al. An MRI and proton spectroscopy study of the thalamus in children with autism. Psychiatry Res 2008; 163: 97-105
52. Endo T, Shioiri T, Kitamura H, Kimura T, Endo S, Masuzawa N et al. Altered chemical metabolites in the amygdala-hippocampus region contribute to autistic symptoms of autism spectrum disorders. Biol Psychiatry 2007; 62: 1030-1037
53. Fayed N, Modrego PJ. Comparative study of cerebral white matter in autism and attention-deficit/hyperactivity disorder by means of magnetic resonance spectroscopy. Acad Radiol 2005; 12: 566-569
54. Murphy DG, Critchley HD, Schmitz N, McAlonan G, Van Amelsvoort T, Robertson D et al. Asperger syndrome: a proton magnetic resonance spectroscopy study of brain. Arch Gen Psychiatry 2002; 59: 885-891
55. Page LA, Daly E, Schmitz N, Simmons A, Toal F, Deeley Q et al. In vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism. Am J Psychiatry 2006; 163: 2189-2192
56. Friedman SD, Shaw DW, Artru AA, Dawson G, Petropoulos H, Dager SR. Gray and white matter brain chemistry in young children with autism. Arch Gen Psychiatry 2006; 63: 786-794
57. Oner O, Devrimci-Ozguven H, Oktem F, Yagmurlu B, Baskak B, Munir KM. Proton MR spectroscopy: higher right anterior cingulate N-acetylaspartate/choline ratio in Asperger syndrome compared with healthy controls. AJNR Am J Neuroradiol 2007; 28: 1494-1498
58. Harada M, Taki MM, Nose A, Kubo H, Mori K, Nishitani H et al. Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument. J Autism Dev Disord 2011; 41: 447-454
59. Vasconcelos MM, Brito AR, Domingues RC, da Cruz LC Jr, Gasparetto EL, Werner J Jr et al. Proton magnetic resonance spectroscopy in school-aged autistic children. J Neuroimaging 2008; 18: 288-295
60. Zeegers M, Van der GJ, Van Daalen E, Buitelaar J, Van Engeland H. Proton magnetic resonance spectroscopy in developmentally delayed young boys with or without autism. J Neural Transm 2007; 114: 289-295
61. Kubas B, Kulak W, Sobaniec W, Tarasow E, Lebkowska U, Walecki J. Metabolite alterations in autistic children: a 1H MR spectroscopy study. Adv Med Sci 2012; 57: 152-156
62. Bejjani A, O'Neill J, Kim JA, Frew AJ, Yee VW, Ly R et al. Elevated glutamatergic compounds in pregenual anterior cingulate in pediatric autism spectrum disorder demonstrated by 1H MRS and 1H MRSI. PLoS One 2012; 7: e38786
63. Joshi G, Biederman J, Wozniak J, Goldin RL, Crowley D, Furtak S., et al. Magnetic resonance spectroscopy study of the glutamatergic system in adolescent males with high-functioning autistic disorder: a pilot study at 4T. Eur Arch Psychiatry Clin Neurosci 2012; 263: 379-384
64. Aoki Y, Abe O, Yahata N, Kuwabara H, Natsubori T, Iwashiro N., et al. Absence of age-related prefrontal NAA change in adults with autism spectrum disorders. Transl Psychiatry 2012; 2: e178
65. Mori K, Toda Y, Ito H, Mori T, Goji A, Fujii E., et al. A proton magnetic resonance spectroscopic study in autism spectrum disorders: amygdala and orbitofrontal cortex. Brain Dev 2013; 35: 139-145
66. Brown MS, Singel D, Hepburn S, Rojas DC. Increased glutamate concentration in the auditory cortex of persons with autism and first-degree relatives: a (1)H-MRS study. Autism Res 2013; 6: 1-10
67. Rojas DC, Singel D, Steinmetz S, Hepburn S, Brown MS. Decreased left perisylvian GABA concentration in children with autism and unaffected siblings. Neuroimage 2013; 86: 28-34
68. Aoki Y, Kasai K, Yamasue H. Age-related change in brain metabolite abnormalities in autism: a meta-analysis of proton magnetic resonance spectroscopy studies. Transl Psychiatry 2012; 2: e69
69. Ipser JC, Syal S, Bentley J, Adnams CM, Steyn B, Stein DJ. 1H-MRS in autism spectrum disorders: a systematic meta-analysis. Metab Brain Dis 2012; 27: 275-287
70. Philipsen A, Graf E, Jans T, Matthies S, Borel P, Colla M., et al. A randomized controlled multicenter trial on the multimodal treatment of adult attentiondeficit hyperactivity disorder: enrollment and characteristics of the study sample. Atten Defic Hyperact Disord 2014; 6: 35-47
71. Baron-Cohen S, Wheelwright S, Skinner R, Martin J, Clubley E. The autismspectrum quotient (AQ): evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord 2001; 31: 5-17
72. Baron-Cohen S, Wheelwright S. The empathy quotient: an investigation of adults with Asperger syndrome or high functioning autism, and normal sex differences. J Autism Dev Disord 2004; 34: 163-175
73. Garnett M, Attwood T. The diagnosis. In: Attwood T (ed). Asperger's Syndrome: a Guide for Parents and Professionals. Jessica Kingsley: London, UK, 1998
74. Constantiono JN, Gruber CP. Social Responsiveness Scale. Western Psychological Services: Los Angeles, CA, USA, 2005
75. Vorst HCM, Bermond B. Validity and reliability of the Bermond-Vorst Alexithymia Questionnaire. Pers Indiv Differ 2001; 30: 413-421
76. Baron-Cohen S, Wheelwright S, Robinson J, Woodbury-Smith M. The Adult Asperger Assessment (AAA): a diagnostic method. J Autism Dev Disord 2005; 35: 807-819
77. Retz-Junginger P, Retz W, Blocher D, Weijers HG, Trott GE, Wender PH., et al. Wender Utah Rating Scale (WURS-K). Nervenarzt 2002; 73: 830-838
78. Hautzinger M. The Beck Depression Inventory (BDI) in clinical use. [German] Nervenarzt 1997; 62: 28-34
79. Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994; 24: 659-685
80. Lord C, Risi S, Lambrecht L, Cook EH Jr, Leventhal BL, DiLavore PC., et al. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 2000; 30: 205-223
81. Lehrl S. Mehrfachwahl-Wortschatz-Intelligenztest (MWT-B). Spitta Verlag: Balingen, Germany, 1999
82. Provencher SW. LC Model and LCMgui. User's Manual http://s-provencher.com/pub/LCModel/manual/manual.pdf 2005
83. Bolliger CS, Boesch C, Kreis R. On the use of Cramér-Rao minimum variance bounds for the design of magnetic resonance spectroscopy experiments. Neuroimage 2013; 83: 1031-1040
84. Bush G, Luu P, Posner MI. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 2000; 4: 215-222
85. MacDonald AW III, Cohen JD, Stenger VA, Carter CS. Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control. Science 2000; 288: 1835-1838
86. Decety J. The neurodevelopment of empathy in humans. Dev Neurosci 2010; 32: 257-267
87. Vollm BA, Taylor AN, Richardson P, Corcoran R, Stirling J, McKie S., et al. Neuronal correlates of theory of mind and empathy: a functional magnetic resonance imaging study in a nonverbal task. Neuroimage 2006; 29: 90-98
88. Hopkins WD, Taglialatela JP. Initiation of joint attention is associated with morphometric variation in the anterior cingulate cortex of chimpanzees (pan troglodytes). Am J Primatol 2013; 75: 441-449
89. Williams JH, Waiter GD, Gilchrist A, Perrett DI, Murray AD, Whiten A. Neural mechanisms of imitation and 'mirror neuron' functioning in autistic spectrum disorder. Neuropsychologia 2006; 44: 610-621
90. Chang SW, Gariepy JF, Platt ML. Neuronal reference frames for social decisions in primate frontal cortex. Nat Neurosci 2013; 16: 243-250
91. Minshew NJ, Keller TA. The nature of brain dysfunction in autism: functional brain imaging studies. Curr Opin Neurol 2010; 23: 124-130
92. Thakkar KN, Polli FE, Joseph RM, Tuch DS, Hadjikhani N, Barton JJ., et al. Response monitoring, repetitive behaviour and anterior cingulate abnormalities in autism spectrum disorders (ASD). Brain 2008; 131: 2464-2478
93. Marsh LE, Hamilton AF. Dissociation of mirroring and mentalising systems in autism. Neuroimage 2011; 56: 1511-1519
94. Baron-Cohen S, Ring H, Moriarty J, Schmitz B, Costa D, Ell P. Recognition of mental state terms. Clinical findings in children with autism and a functional neuroimaging study of normal adults. Br J Psychiatry 1994; 165: 640-649
95. Haznedar MM, Buchsbaum MS, Metzger M, Solimando A, Spiegel-Cohen J, Hollander E. Anterior cingulate gyrus volume and glucose metabolism in autistic disorder. Am J Psychiatry 1997; 154: 1047-1050
96. Haznedar MM, Buchsbaum MS, Wei TC, Hof PR, Cartwright C, Bienstock CA., et al. Limbic circuitry in patients with autism spectrum disorders studied with positron emission tomography and magnetic resonance imaging. Am J Psychiatry 2000; 157: 1994-2001
97. Nakamura K, Sekine Y, Ouchi Y, Tsujii M, Yoshikawa E, Futatsubashi M., et al. Brain serotonin and dopamine transporter bindings in adults with highfunctioning autism. Arch Gen Psychiatry 2010; 67: 59-68
98. Simms ML, Kemper TL, Timbie CM, Bauman ML, Blatt GJ. The anterior cingulate cortex in autism: heterogeneity of qualitative and quantitative cytoarchitectonic features suggests possible subgroups. Acta Neuropathol 2009; 118: 673-684
99. Oblak AL, Gibbs TT, Blatt GJ. Decreased GABA(B) receptors in the cingulate cortex and fusiform gyrus in autism. J Neurochem 2010; 114: 1414-1423
100. Tebartz Van Elst LT, Thiel T, Hesslinger B, Lieb K, Bohus M, Hennig J., et al. Subtle prefrontal neuropathology in a pilot magnetic resonance spectroscopy study in patients with borderline personality disorder. J Neuropsychiatry Clin Neurosci 2001; 13: 511-514
101. Tebartz Van Elst L, Ludaescher P, Thiel T, Büchert M, Hesslinger B, Bohus M., et al. Evidence of disturbed amygdalar energy metabolism in patients with borderline personality disorder. Neurosci Lett 2007; 417: 36-41
102. Yizhar O, Fenno LE, Prigge M, Schneider F, Davidson TJ, O'Shea DJ., et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 2011; 477: 171-178
103. Gogolla N, Leblanc JJ, Quast KB, Südhof TC, Fagiolini M, Hensch TK. Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J Neurodev Disord 2009; 1: 172-181
104. Ramocki MB, Zoghbi HY. Failure of neuronal homeostasis results in common neuropsychiatric phenotypes. Nature 2008; 455: 912-918
105. Tabuchi K, Blundell J, Etherton MR, Hammer RE, Liu X, Powell CM., et al. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007; 318: 71-76
106. Tebartz Van Elst L, Krishnamoorthy ES, Schulze-Bonhage A, Altenmüller DM, Richter H, Ebert D., et al. Local area network inhibition: a model of a potentially important paraepileptic pathomechanism in neuropsychiatric disorders. Epilepsy Behav 2011; 22: 231-239
107. Soher BJ, Doraiswamy PM, Charles HC. A review of 1H MR spectroscopy findings in Alzheimer's disease. Neuroimaging Clin N Am 2005; 15: 847-852, xi.
108. Casanova MF, El-Baz A, Vanbogaert E, Narahari P, Switala A. A topographic study of minicolumnar core width by lamina comparison between autistic subjects and controls: possible minicolumnar disruption due to an anatomical element in-common to multiple laminae. Brain Pathol 2010; 20: 451-458
109. Dautry C, Vaufrey F, Brouillet E, Bizat N, Henry PG, Condé F., et al. Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid. J Cereb Blood Flow Metab 2000; 20: 789-799
110. Perlov E, Philipsen A, Matthies S, Drieling T, Maier S, Bubl E., et al. Spectroscopic findings in attention-deficit/hyperactivity disorder: review and meta-analysis. World J Biol Psychiatry 2009; 10: 355-365
111. Doelken MT, Mennecke A, Stadlbauer A, Kecskeméti L, Kasper BS, Struffert T., et al. Multi-voxel magnetic resonance spectroscopy at 3 T in patients with idiopathic generalised epilepsy. Seizure 2010; 19: 485-492
112. Peca S, Carnì M, Di Bonaventura C, Aprile T, Hagberg GE, Giallonardo AT., et al. Metabolic correlatives of brain activity in a FOS epilepsy patient. NMR Biomed 2010; 23: 170-178
113. Zahr NM, Crawford EL, Hsu O, Vinco S, Mayer D, Rohlfing T., et al. In vivo glutamate decline associated with kainic acid-induced status epilepticus. Brain Res 2009; 1300: 65-78
114. Vezzani A, Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 2005; 46: 1724-1743
115. Tetreault NA, Hakeem AY, Jiang S, Williams BA, Allman E, Wold BJ., et al. Microglia in the cerebral cortex in autism. J Autism Dev Disord 2012; 42: 2569-2584
116. Degos V, Peineau S, Nijboer C, Kaindl AM, Sigaut S, Favrais G., et al. G proteincoupled receptor kinase 2 and group I metabotropic glutamate receptors mediate inflammation-induced sensitization to excitotoxic neurodegeneration. Ann Neurol 2013; 73: 667-678
117. Takaki J, Fujimori K, Miura M, Suzuki T, Sekino Y, Sato K. L-glutamate released from activated microglia downregulates astrocytic L-glutamate transporter expression in neuroinflammation: the 'collusion' hypothesis for increased extracellular L-glutamate concentration in neuroinflammation. J Neuroinflammation 2012; 9: 275
118. Gupta RK, Yadav SK, Rangan M, Rathore RK, Thomas MA, Prasad KN., et al. Serum proinflammatory cytokines correlate with diffusion tensor imaging derived metrics and 1H-MR spectroscopy in patients with acute liver failure. Metab Brain Dis 2010; 25: 355-361
119. Ringheim GE, Szczepanik AM. Brain inflammation, cholesterol, and glutamate as interconnected participants in the pathology of Alzheimer's disease. Curr Pharm Des 2006; 12: 719-738
120. McNally L, Bhagwagar Z, Hannestad J. Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr 2008; 13: 501-510
121. Brugha TS, McManus S, Smith J, Scott FJ, Meltzer H, Purdon S., et al. Validating two survey methods for identifying cases of autism spectrum disorder among adults in the community. Psychol Med 2012; 42: 647-656
122. Bastiaansen JA, Meffert H, Hein S, Huizinga P, Ketelaars C, Pijnenborg., et al. Diagnosing autism spectrum disorders in adults: the use of Autism Diagnostic Observation Schedule (ADOS) module 4. J Autism Dev Disord 2011; 41: 1256-1266
123. Becker J, Kamp-Becker I. Die Diagnose des Asperger Syndroms bei erwachsenen Menschen, klinische Erfahrungen unter besonderer Berücksichtigung Der Diagnostischen Beobachtungssklala für Autistische Störungen (ADOS). 5. Wissenschaftliche Tagung Autismus Spektrum: 29. 2012. Wissenschaftliche Gesellschaft Autismus Spektrum. Tagungsband
124. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001; 14: 260-264